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Invasive fungal infections represent an increasing problem associated with high mortality. The present study
was undertaken to identify leukocyte subsets that are activated by hyphal fragments in a whole-human-blood
model, as well as to examine the involvement of CD14 and Toll-like receptors (TLRs) in activation of monocytes
by hyphae. Incubation of whole human blood with hyphal fragments from Aspergillus fumigatus and Scedospo-
rium prolificans for 6 h caused induction of mRNAs for tumor necrosis factor alpha (TNF-a), interleukin-1b
(IL-1b), and IL-6 in T cells, B cells, and monocytes, but not in granulocytes, as analyzed by reverse transcrip-
tion-PCR with mRNA isolated from very pure populations of these leukocyte subsets. In primary adherent
human monocytes, induction of TNF-a by hyphal fragments was dependent on plasma. Heat treatment of
plasma at 56°C for 30 min strongly reduced the ability of plasma to prime for activation. Pretreatment of
human monocytes with different concentrations (1, 3, and 10 mg/ml) of monoclonal antibody (MAb) HTA125
(anti-TLR4) or MAb 18D11 (anti-CD14) for 30 min inhibited the release of TNF-a induced by hyphal
fragments in a dose-dependent manner. Maximal inhibitions of 35 and 70% were obtained with 10 mg of
HTA125 and 18D11 per ml, respectively. In contrast, pretreatment with MAb TL2.1 (anti-TLR2) did not affect
signaling induced by hyphae. Pretreatment with the lipid A antagonist B975 blocked lipopolysaccharide
signaling but did not inhibit TNF-a production induced by hyphal fragments. Our results suggest that T cells,
B cells, and monocytes are involved in the innate immune response to invasive fungal pathogens and that
serum components are relevant for activation of monocytes by hyphae. CD14 and TLR4 may be involved in
signaling of Aspergillus hyphae in monocytes, but further studies to elucidate this issue are warranted.
Sepsis caused by fungal infections is a major and increasing
problem that is responsible for high rates of morbidity and
mortality (6, 19, 37). As the number of immunocompromised
patients has increased, invasive aspergillosis has become the
second most common opportunistic fungal infection (1, 11).
The major host defense against invasive aspergillosis has been
shown to be mediated by cells of the innate immune system.
Macrophages in the lung ingest inhaled airborne Aspergillus
conidia and thereby inhibit their intracellular germination (16,
31, 36). In addition, polymorphonuclear leukocytes, as well as
monocytes, cause damage to escaping conidia and hyphae by
secretion of oxidative metabolites and nonoxidative com-
pounds, thereby preventing establishment of invasive infec-
tions (7, 16, 31).
The role of cytokines in the host response to Aspergillus has
just recently begun to be elucidated (3, 4, 28–30). It was re-
cently demonstrated that killed hyphal fragments and, to a
lesser degree, conidia from Aspergillus fumigatus provoke an
inflammatory response in whole human blood (A. Warris, J. E.
Wang, P. E. Verweij, P. Gaustad, and T. G. Abrahamsen,
unpublished data), as seen by release of the proinflammatory
cytokines tumor necrosis factor alpha (TNF-a) and interleu-
kin-6 (IL-6). The anti-inflammatory cytokine IL-10 was not
significantly induced by any of the fungal structures. The chain
of events that leads to activation of human leukocytes by fungal
structures is still elusive.
The Toll protein in Drosophila was recently demonstrated as
being involved in dorsoventral patterning in embryonic devel-
opment (2), as well as mediating antifungal defense in the
adult fly (15). Mammalian homologues of Toll, termed Toll-
like receptors (TLRs), have been cloned (22), and TLRs are
attributed key roles in the induction of immunity (20, 21).
Today, only two of these receptors have any known ligands.
TLR4 has been shown to mediate cell signaling by lipopoly-
saccharide (LPS) (27, 34), whereas TLR2 has been implicated
in the response to diverse bacterial products (9, 17). Despite
their role in antifungal defense in the fly, the involvement of
TLRs in the host response to fungal pathogens in mammals
has not previously been studied.
The present study examined the influence of blockade of
CD14, TLR2, and TLR4 with specific monoclonal antibodies
(MAbs) on activation of human monocytes by hyphal frag-
ments. The requirement of plasma for cell activation by hyphae
was also studied. Finally, we have identified the leukocyte
subsets responsible for cytokine release in whole blood stimu-
lated with hyphal fragments from A. fumigatus or Scedosporium
prolificans.
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Reagents and antibodies. MAb TL2.1 was generated as previously described
(9). MAb HTA125 was a kind gift from Kensuke Miyake (Saga Medical School,
Saga, Japan) (32). A MAb against CD14 (18D11) and a negative control anti-
body (immunoglobulin G1 [IgG1]) were purchased from Diatec AS (Oslo, Nor-
way). B975 is a synthetic analogue of Rhodobacter capsulatus lipid A, provided by
D. P. Rossignol and W. J. Christ (Eisai Research Institute, Andover, Mass.) (26).
Isolation of killed hyphal fragments. The A. fumigatus and S. prolificans strains
used in this study were obtained from clinical isolates of invasive aspergillosis and
scedosporiosis, respectively. The strains were grown on Sabouraud glucose agar
supplemented with penicillin-streptomycin for 4 to 7 days at 35°C. Abundant
conidia were elaborated under these conditions. Conidia were harvested by
gently scraping the surfaces of the slants and suspending them in phosphate-
buffered saline (PBS). To suspend the very hydrophobic conidia of A. fumigatus,
0.05% Tween 80 was added to the PBS. To remove hyphae and debris, the
conidial suspension was filtered through eight layers of cheesecloth. Hyphal
fragments were developed from these conidia as previously described (Warris et
al., unpublished). In brief, conidia from both A. fumigatus and S. prolificans were
added to 5 ml of yeast nitrogen base (Difco Laboratories, Detroit, Mich.) in a
final concentration of 106 conidia per ml. After 18 h of incubation at 37°C, the
tubes were centrifuged (2,800 3 g for 10 min) in order to spin down the pellet.
The pellet, containing almost exclusively mycelia, was washed twice in Hanks
balanced saline solution without Ca21 and Mg21 (HBSS w/o). The mycelia were
resuspended in ethanol-PBS (70%) and stored in a refrigerator for 24 h. The
sterilized hyphae were centrifuged and resuspended vigorously in PBS containing
10 mg of RNase A (from bovine pancreas; Sigma-Aldrich, St. Louis, Mo.) per ml
and incubated for 30 min at 37°C to remove intracellular RNA. Finally, the
hyphal fragments were washed three times with HBSS w/o, and aliquots of 1.5 ml
containing hyphal fragments from, initially, 5 3 106 conidia were stored at
280°C. The lack of viability after ethanol treatment was always confirmed by
culture in Sabouraud glucose broth. Microscopically, the morphology of the
killed hyphal fragments seemed intact.
Whole-blood experiments. The whole-blood model used in this study has
recently been established and characterized (38). Venous blood from healthy
volunteers was anticoagulated with heparin (30 IU per ml of blood). Blood was
incubated in Monovette syringes (Sarstedt, Germany) in the absence or presence
of hyphal fragments from A. fumigatus or S. prolificans or of LPS (Escherichia coli
O26:B7; Difco Laboratories). At indicated time points, leukocyte subsets or
plasma was isolated.
Primary adherent monocytes. Peripheral blood mononuclear cells (PBMCs)
were isolated from heparinized human blood (30 IU per ml of blood) (24).
PBMCs (3 3 106 to 4 3 106 per ml) were seeded at 200 ml per well in 96-well
dishes (Costar). Monocytes were allowed to adhere for 90 min in 5% CO2 at
37°C before being washed three times in HBSS. For blockade of receptors,
monocytes were incubated at room temperature with various doses of MAbs
HTA125 (anti-TLR4), TL2.1 (anti-TLR2), and 18D11 (anti-CD14); IgG1 control
antibody; or the B975 lipid A antagonist in RPMI medium under serum-free con-
ditions. The monocytes were subsequently added to a mixture of 5% autologous
plasma and hyphal fragments (15 ml of hyphal suspension grown from 3.3 3 106
conidia) or LPS. Supernatants were collected after 8 h and stored at 220°C.
Fractionation of leukocytes. CD141 cells were isolated from whole blood as
previously described (33). In brief, Dynabeads M450 CD14 (Dynal, Oslo, Nor-
way) were used to isolate a pure population of leukocytes expressing the CD14
receptor (monocytes, macrophages, and a subset of granulocytes). Fifty micro-
liters of Dynabeads (4 3 108 beads per ml) was used per 400 ml of blood. The
beads and blood were incubated with gentle rotation for 5 min at 4°C and
subsequently placed on a magnet (MPC 6; Dynal) for 3 min. After being washed
twice in cold PBS, the cells were lysed by addition of 300 ml of lysis-and-binding
buffer (Dynal). The lysates were used directly for mRNA isolation or frozen at
220°C.
Pure populations of T cells (CD21), granulocytes (CD151), and B cells (CD19
positive) were isolated in a similar manner from 400, 800, and 100 ml of blood,
respectively, in accordance with protocols provided by the manufacturer (Dynal).
Isolation of mRNA. Isolation of mRNA was carried out as previously described
(33), with oligo(dT)25-coated Dynabeads (Dynal). Briefly, 30 ml of prewashed
oligo(dT)25 (5 mg/ml)-coated Dynabeads and lysates from CD21, CD141,
CD151, or CD191 cells were rotated for 5 min at room temperature. After a
thorough washing, the mixture of beads and mRNA was resuspended in 20 ml of
diethyl pyrocarbonate-treated distilled water and used directly in reverse tran-
scription-PCR (RT-PCR) or frozen at 220°C.
RT-PCR. Semiquantitative analyses of cytokine mRNA expression were per-
formed by RT-PCR according to a previously described protocol (33). Briefly,
RT and PCR were performed in a PCR Cycler (GeneAmp 9600; Perkin-Elmer
Cetus Corp., Norwalk, Conn.). Synthesis of cDNA was performed by RT directly
on the mRNA attached to the oligo(dT)25 beads by using a GeneAmp RNA PCR
kit (Perkin-Elmer). Subsequently, the cDNA pool was analyzed by PCR for
cDNA specific for TNF-a, IL-6, IL-10, and b-actin with specific primers as
previously described (33).
Plasma cytokine analysis. At the indicated times, plasma was removed from
the blood by centrifugation at 7,000 3 g for 2 min and stored at 220°C for later
analyses by enzyme immunoassay (EIA) specific for TNF-a according to proto-
cols provided by the manufacturer (CLB, Amsterdam, The Netherlands). The
detection limit was 1 pg/ml.
Statistical evaluation. Data are presented as means 6 standard errors. Stu-
dent’s t test or analysis of variance with Tukey’s post hoc assessment was used to
evaluate the statistical significance of the results. Differences with P values of
,0.05 were considered significant.
RESULTS
Cytokine mRNAs in leukocyte subsets. Figure 1 shows ac-
cumulation of mRNAs for TNF-a (A), IL-1b (B), IL-6 (C),
and b-actin (D) in pure populations of leukocyte subsets iso-
lated after stimulation of whole human blood with hyphal
fragments from A. fumigatus or S. prolificans, as detected by
RT-PCR. Figure 1A shows that TNF-a mRNA was detected in
all leukocyte subsets in unstimulated blood (lanes 1 to 4).
Stimulation with hyphal fragments from A. fumigatus or S.
prolificans caused enhanced levels of TNF-a mRNA in mono-
cytes (lanes 5 and 9), T cells (lanes 7 and 11), and B cells (lanes
8 and 12), but not in granulocytes (lanes 6 and 10). Neither
IL-1b mRNA (Fig. 1B) nor IL-6 mRNA (Fig. 1C) was detected
in leukocytes isolated from unstimulated blood (lanes 1 to 4).
In contrast, in blood treated with hyphae from A. fumigatus or
S. prolificans, IL-1b mRNA was strongly induced in monocytes
(lanes 5 and 9). Low levels of IL-1b were also detected in
granulocytes (lanes 6 and 10), T cells (lanes 7 and 11), and B
cells (lanes 8 and 12). Figure 1C shows that, similar to TNF-a,
IL-6 mRNA was induced in monocytes (lanes 5 and 9), T cells
(lanes 7 and 11), and B cells (lanes 8 and 12), but not in
granulocytes (lanes 6 and 10).
Dependency on plasma for stimulation of human monocytes
by hyphal fragments. Figure 2A shows that hyphal fragments
FIG. 1. Expression of mRNAs for TNF-a, IL-1b, IL-6, and b-actin
in various leukocyte populations 6 h after incubation of whole blood in
the absence (lanes 1 to 4) or presence of hyphal fragments isolated
from A. fumigatus (lanes 5 to 8) or S. prolificans (lanes 9 to 12).
Monocytes (CD141), granulocytes (CD151), T cells (CD21), and B
cells (CD191) were isolated by immunomagnetic separation. mRNA
from these cells was isolated by oligo(dT)25-coated magnetic beads,
reverse transcribed, and analyzed for transcripts encoding TNF-a (A
[443 bp]), IL-1b (B [802 bp]), IL-6 (C [628 bp]), and b-actin (D [660
bp]) by PCR. Unstim., unstimulated.
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were unable to induce TNF-a release from primary adherent
human monocytes in the absence of plasma. Stimulation of
monocytes by hyphal fragments (A. fumigatus) in the presence
of autologous plasma (1, 5, and 10%) resulted in induction of
TNF-a production in a plasma dose-dependent manner. Heat
treatment of plasma at 56°C for 30 min to inactivate comple-
ment strongly reduced TNF-a production (Fig. 2B).
Blockade of signaling events. Pretreatment of human mono-
cytes with MAb HTA125 (anti-TLR4) or 18D11 (anti-CD14)
inhibited the production of TNF-a induced by Aspergillus hy-
phae in a dose-dependent manner (Fig. 3A). Maximal inhibi-
tion levels of 35 and 70% were obtained with 10 mg of HTA125
or 18D11 per ml, respectively. Pretreatment with TL2.1 or an
isotype control (IgG1) antibody did not inhibit the release of
TNF-a induced by hyphal fragments. In comparison, HTA125
and 18D11 at 10 mg/ml inhibited LPS-induced TNF-a by 85
and 95%, respectively (Fig. 3B), whereas this stimulation was
not influenced by TL2.1 or the control antibody. Figure 4
shows that pretreatment of human monocytes with a synthetic
analogue of Rhodobacter capsulatus (B975) (26) inhibited LPS-
induced release of TNF-a in a dose-dependent manner. At 100
nM B975, the TNF-a release induced by LPS was completely
blocked. In contrast, B975 did not influence the TNF-a release
induced by hyphal fragments.
DISCUSSION
This is the first study of the involvement of TLRs in the host
response to filamentous fungal pathogens. The partial inhibi-
tion of hypha-induced activation observed with antibodies
against TLR4 and CD14 suggests that several receptors may be
involved, of which TLR4 and CD14 are two candidates. A
receptor complex consisting of TLR4, CD14, and MD-2 me-
diates LPS signaling (27, 34). This may suggest that hyphae
stimulate cells through mechanisms partly similar to those of
LPS. Compared with control antibody, a weak inhibition was
also obtained with TL2.1 (anti-TLR2), and we cannot rule out
a role for TLR2 in hyphal signaling. Another interpretation of
these results is that different TLRs are actually involved. The
weak and partial inhibition of monocyte activation by anti-
TLR2 and anti-TLR4 antibodies may be attributed to cross-
reactivities with yet uncharacterized TLRs. The immunostimu-
latory molecule(s) in the hyphal fragments that interacts with
pathogen recognition receptors on monocytes is not known.
The hyphal cell wall consists of b-glucan and galactomannan,
which have immunogenic properties (12). An undefined “en-
dotoxin” derived from A. fumigatus mycelia that is toxic in
animal models of aspergillosis has also been described (5). The
latter study supports the contention that hyphae may activate
LPS signaling pathways. However, the failure of a lipid A
antagonist to interfere with hyphal stimulation demonstrates
that hyphae activate cells differently from LPS. More studies
are clearly warranted to elucidate the involvement of CD14
and TLRs in recognition and signaling of hyphae in vitro and
in vivo, as well as the roles of these receptors during invasive
fungal infections.
We observed an absolute requirement of serum for activa-
tion of human monocytes by hyphae. Plasma contains secreted
pathogen recognition receptors such as LPS-binding protein
(LBP), soluble CD14 (sCD14), and mannan-binding lectin (re-
viewed in reference 20). Mannan-binding lectin opsonizes
FIG. 2. Dependency on plasma for stimulation of TNF-a release by
human monocytes (four donors) by hyphal fragments from A. fumiga-
tus. (A) Human monocytes isolated from whole blood were spiked with
autologous plasma (0, 1, 5, or 10%) and cultured for 8 h in the absence
or presence of hyphal fragments. (B) Monocytes were stimulated with
hyphal fragments in the presence of 5% untreated plasma or 5%
plasma that had been heat treated at 56°C for 30 min. Supernatants
were subsequently analyzed for TNF-a by EIA. Data are means 6
standard errors of four experiments. p, significantly lower (P , 0.05)
than values obtained with untreated plasma, as calculated by Student’s
t test.
FIG. 3. Influence of blockade of CD14, TLR4, and TLR2 on pri-
mary adherent monocytes by MAbs on stimulation of TNF-a produc-
tion by Aspergillus hyphae (A) and LPS (B). Human monocytes were
pretreated with different concentrations (1, 3, or 10 mg/ml) of 18D11
(anti-CD14), HTA125 (anti-TLR4), TL2.1 (anti-TLR2), or an IgG1
control antibody for 30 min at room temperature under serum-free
conditions. Hyphal fragments and 5% plasma (or LPS [10 ng/ml]) were
subsequently added, followed by incubation for 8 h. Supernatants were
analyzed for TNF-a by EIA. Results are means 6 standard errors of
six to nine experiments. p, significantly lower (P , 0.05) than values
obtained with control antibodies, as calculated by analysis of variance.
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mannan for presentation to signaling receptors (8, 10). Binding
of microbial ligand to mannan-binding lectin results in an am-
plified cascade of complement activation (8), and Aspergillus
hyphae have indeed been demonstrated to activate comple-
ment via both the alternative and classical pathways in human
serum (13, 14). A role for mannan-binding lectin in the innate
response to fungal infections, however, has not yet been dem-
onstrated (20). In support of the contention that activation of
leukocytes is mediated by complement, inactivation of comple-
ment by heat treatment strongly attenuated activation in the
present study. Hence, studies of complement receptor involve-
ment in activation of monocytes by hyphae are warranted.
Inactivation of complement by heat treatment did not result in
complete loss of leukocyte activation, which suggests that other
factors in the plasma, such as LBP and sCD14, also may be
involved in cellular activation by hyphae. Alternatively, the
residual activation obtained by heat-treated plasma may also
be due to cross-linking of Fc receptors by natural antibodies to
hyphae. Further studies are clearly needed to dissect the basis
for the serum requirements observed in the present study.
This is the first report on the induction by hyphae of mRNAs
for TNF-a, IL-1b, and IL-6 in leukocytes. The ability of hyphae
to induce cytokine release has been previously observed by
us and others (35; Warris et al., unpublished). That cytokine
mRNAs were increased in T cells, B cells, and monocytes in
blood stimulated with hyphal fragments suggests that these
leukocyte subsets contribute to the cytokine production during
invasive fungal infection. This notion is supported by the fact
that a similar pattern was seen with hyphal fragments isolated
from two different fungal pathogens. Furthermore, the fact
that hyphal fragments induce cytokine production in several
leukocyte subsets supports the contention that cytokines play
important roles in the host’s defense against fungal pathogens
(3, 4, 28–30). The failure of hyphal fragments to induce cyto-
kine mRNA production in granulocytes is somewhat surpris-
ing. Polymorphonuclear leukocytes, as well as circulating
monocytes, are thought to represent the major host defense
against invasive fungal infections, by secretion of microbicidal
compounds (7, 16, 31). However, hyphal structures are too
large to be phagocytosed and thus have to be attacked extra-
cellularly. This calls upon other cell types, such as B cells and
T cells. Whether NK cells may also play a role in this respect
is not known. The cytokine pattern induced by hyphae in the
present study is partly different from what has been previously
reported with bacterial components, in which only T cells and
monocytes were activated (39). A role for lymphocytes in in-
nate immune responses has gained new support due to the
recent discovery that members of the TLR family are ex-
pressed on mammalian T cells (18, 23) and B cells (25).
Our data suggest that T cells, B cells, and monocytes are
involved in the innate host response to invasive fungal infec-
tions and that serum components are relevant for activation of
monocytes by hyphae. CD14 and TLR4 may be involved in
signaling of Aspergillus hyphae in monocytes, but further stud-
ies are warranted to elucidate this issue.
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